Ulanqab Kema New Material Shines at API China in Chongqing
In the mountainous city of Chongqing this November, the vitality of innovation remains undimmed. From November 12th to 14th, 2024, the highly anticipated 93rd China International Pharmaceutical Ingredients & Intermediates / Packaging / Equipment Trade Fair (The 93rd API China) grandly commenced at the Chongqing International Expo Center. At this annual event renowned as the "barometer of China's pharmaceutical ingredient industry," Ulanqab Kema New Material Co., Ltd., as a rapidly emerging force, made a dazzling appearance with its leading innovative products and solutions, becoming one of the focal points of attention at the exhibition.
Industry Gathering Paints New Chapter for Pharmaceuticals
This edition of API China boasted an unprecedented scale, convening top-tier global manufacturers of pharmaceutical ingredients, intermediates, packaging, and equipment. The exhibition served not only as a platform for product display but also as a highland for releasing industry trends, facilitating technical exchange, and fostering business collaboration. Guided by the theme of "Innovation, Green, Intelligence," enterprises from across the industrial chain gathered to jointly explore new pathways and futures for the high-quality development of the pharmaceutical industry.
At the booth, a steady stream of clients engaged in inquiries and negotiations. The company's technical and commercial representatives enthusiastically introduced the core technical advantages of the products, the stringent quality control system, and the capabilities for customized services. The diverse range of high-purity, low-impurity, high-quality products compliant with international standards showcased by Kema New Material fully embodied its development philosophy of "driven by technological innovation and guided by customer needs," garnering widespread recognition and acclaim from numerous potential partners.
Innovation-Driven Approach Empowers Pharmaceutical Industry Upgrade
"Participating in API China this time was a highly significant opportunity for demonstration and exchange for us," stated a representative from Ulanqab Kema New Materials Co., Ltd. "We not only demonstrated Kema's strength and determination to the industry but also, through in-depth communication with both new and existing clients, accurately grasped the market pulse and cutting-edge demands. The dynamic city of Chongqing has witnessed the close connection between Kema New Materials and the national, even global, pharmaceutical industrial chain."
Through this exhibition, Ulanqab Kema New Material Co., Ltd. successfully enhanced its brand visibility, expanded its business cooperation network, and reached preliminary cooperation consensus with multiple prospective clients. The company stated that it will continue to increase investment in research and development, uphold product quality as its lifeline, and remain committed to providing safer, more reliable, and more efficient new material solutions for global pharmaceutical enterprises, contributing "Kema's Strength" to the advancement of pharmaceutical and health endeavors in China and worldwide.
In the early winter of Chongqing, the warmth was palpable, fueled by this grand industry gathering. The "dazzling debut" of Ulanqab Kema New Material marks not only a successful market initiative but also heralds its ambition and confidence in embarking on a new journey within the field of pharmaceutical new materials.